Similar Search Results

Tax harmonization : the single market challenge

Kanavos, Panos - In: New challenges to the European Union : policies and …, (pp. 269-296). 1997

Persistent link: https://www.econbiz.de/10001296421

Competition in off-patent drug markets : issues, regulation and evidence

Kanavos, Panos; Costa-Font, Joan; Seeley, Elizabeth - In: Economic policy : a European forum 55 (2008), pp. 499-544

Persistent link: https://www.econbiz.de/10003741151

Determinants of out-of-pocket pharmaceutical expenditure and access to drugs in Catalonia

Costa-Font, Joan; Kanavos, Panos; Rovira Forns, Joan - In: Applied economics 39 (2007) 4/6, pp. 541-551

Persistent link: https://www.econbiz.de/10003461955

Competition in prescription drug markets: is parallel trade the answer?

Kanavos, Panos; Vandoros, Sotiris - In: Managerial and decision economics : MDE ; the … 31 (2010) 5, pp. 325-338

Persistent link: https://www.econbiz.de/10003996503

Prescription drug coverage among elderly and disabled Americans : can Medicare-Part D reduce inequalities in access?

Kanavos, Panos; Gemmill-Toyama, Marin - In: International journal of health care finance and economics 10 (2010) 3, pp. 203-218

Persistent link: https://www.econbiz.de/10008648345

Product differentiation, competition and regulation of new drugs : the case of statins in four European countries

Kanavos, Panos; Costa-Font, Joan; McGuire, Alistair - In: Managerial and decision economics : MDE ; the … 28 (2007) 4/5, pp. 455-465

Persistent link: https://www.econbiz.de/10003543710

Commentary

Philipson, Tomas J. - In: Managerial and decision economics : MDE ; the … 28 (2007) 4/5, pp. 467-468

Persistent link: https://www.econbiz.de/10003543714

The effects of drug market regulation on pharmaceutical prices in Europe : overview and evidence from the market of ACE inhibitors

Schulenburg, Fritz von der; Vandoros, Sotiris; Kanavos, … - In: Health economics review 1 (2011) 18, pp. 1-8

This study provides an overview of policy measures targeting pharmaceutical expenditure in Europe and analyses their impact on originator pharmaceutical prices. Panel data methods are used to examine the market of ACE Inhibitors in six European countries (Denmark, France, Germany, Netherlands,...

Persistent link: https://www.econbiz.de/10009503923

The generics paradox revisited : empirical evidence from regulated markets

Vandoros, Sotiris; Kanavos, Panos - In: Applied economics 45 (2013) 22/24, pp. 3230-3239

Persistent link: https://www.econbiz.de/10010345456

Pharmaceutical parallel trade in Europe : stakeholder and competition effects

Kanavos, Panos; Costa-Font, Joan - In: Economic policy : a European forum 44 (2005), pp. 751-798

Persistent link: https://www.econbiz.de/10011517376